NCT00797758已完成2 期
Assessment of Reduction of Cord Blood Transplantation Toxicity by Using Reduced Intensity Conditioning in Patients With Acute Myeloid Leukemia.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 76
- 试验地点
- 2
- 主要终点
- Transplant related mortality
研究概览
简要总结
Multicentric evaluation of the reduction of unrelated cord blood transplantation (UCBT) toxicity by using reduced intensity conditioning (RIC) in patients with acute myeloid leukaemia.UCBT related mortality and morbidity were limiting factors for the development of this procedure in adults. Non myeloablative conditioning regimen showed promising results and prospective evaluation has to be developed to confirm these retrospective data.
详细描述
Individual meta-analysis is planned to compare geno-identical transplantation with myeloid-ablative or non myeloid-ablative conditioning with UCBT after RIC.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 4 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Ages : 4 to 65
- •De novo or secondary AML requiring allogeneic transplant
- •No donor (related or unrelated) compatible 10/10
- •Complete remission excepted CR1 with t(8;21) or inv (16) or t (15;17)
- •Smouldering AML without progression
- •Signed assent of recipient
排除标准
- •If CR1: AML with with t(8;21) or inv (16) or t (15;17)
- •Karnofsky < 50% - Clearance of creatinin < 40 ml/min
- •Transaminases > 8 N
- •Previous autologous or allogeneic transplantation within 6 month prior to the study (except if tandem)
- •total body irradiation contra-indicating 2 Gy TBI
- •local irradiation contra-indicating 2 Gy TBI
结局指标
主要结局
Transplant related mortality
时间窗: At 2 years
次要结局
- Clinical efficiency (overall survival, event free survival, relapse incidence, acute and chronic GVHD incidence, graft failure, venoocclusive disease, interstitial pneumonia, infections, comorbidity score, quality of life and medico-economic impact)(at 2 years)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
不适用
Umbilical Cord Blood Transplant for Children With Lymphoid Hematological MalignanciesLymphoid Hematological MalignanciesUmbilical Cord Blood TransplantNCT01247688Baylor College of Medicine
Unknown
2 期
Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid MalignanciesLeukemia, MyeloidNCT02333838Assistance Publique - Hôpitaux de Paris31
终止
1 期
Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus TransplantationStem Cell TransplantationNCT00597441Sumitomo Pharma Switzerland GmbH6
招募中
不适用
Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBTSevere Aplastic AnemiaNCT06039436Anhui Provincial Hospital72
已完成
2 期
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic DiseasesThymic CarcinomaGraft Versus Host DiseaseMyelodysplastic SyndromesLeukemiaNCT00003662Roswell Park Cancer Institute90